Tripp Levy PLLC Investigates Management Buyout of MedQuist

Tripp Levy PLLC, a leading national securities firm, announces an investigation into the proposed acquisition of MedQuist Inc. (NASDAQ: MEDQ). On January 21, 2011, CBaySystems Holdings Limited announced that it intends to commence an offer to exchange one share of CBay common stock for each outstanding share of MedQuist common stock that it does not currently own or have the right to acquire (the “Exchange Offer”). CBay currently owns approximately 69.5% of MedQuist’s outstanding shares of common stock and has entered into an agreement with certain MedQuist shareholders who own approximately 12.7% of MedQuist’s outstanding shares of common stock to exchange one share of CBay common stock for each share of MedQuist common stock owned by such shareholders (the “Private Exchange”). Assuming consummation of the Private Exchange, a full exchange in the Exchange Offer would increase CBay’s ownership in MedQuist to 100%.

The investigation concerns, among other things, whether the consideration to be paid to MedQuist shareholders is grossly unfair, inadequate, and substantially below the fair or inherent value of MedQuist. The investigation further concerns whether CBay, as the controlling shareholder of the company, as well as the board of directors of MedQuist may have breached their fiduciary duties by not acting in MedQuist shareholders' best interests in connection with the sale process of MedQuist.

If you own MedQuist common stock and you wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact

Tripp LevyTripp Levy PLLC125 East 82nd Street9th FloorNew York, New YorkToll Free: 877-772-3975Email: [e-mail]

Tripp Levy PLLC is a national law firm that specializes in mergers & acquisitions, takeover litigation, shareholder rights, and corporate governance matters in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.